NOVARTIS INDIA
|
NOVARTIS INDIA Last 5 Year Cashflow Statement History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Profit Before Tax | ₹123 Cr | ₹115 Cr | ₹-3.82 Cr | ₹40 Cr | ₹29 Cr |
Adjustment | ₹-57 Cr | ₹-49 Cr | ₹-5.64 Cr | ₹-4.98 Cr | ₹-12 Cr |
Changes In working Capital | ₹9.04 Cr | ₹-24 Cr | ₹67 Cr | ₹-69 Cr | ₹-1.85 Cr |
Cash Flow after changes in Working Capital | ₹75 Cr | ₹42 Cr | ₹57 Cr | ₹-34 Cr | ₹15 Cr |
Cash Flow from Operating Activities | ₹113 Cr | ₹45 Cr | ₹39 Cr | ₹-69 Cr | ₹-23 Cr |
Cash Flow from Investing Activities | ₹33 Cr | ₹-153 Cr | ₹87 Cr | ₹95 Cr | ₹56 Cr |
Cash Flow from Financing Activities | ₹-121 Cr | ₹-30 Cr | ₹-36 Cr | ₹-37 Cr | ₹-41 Cr |
Net Cash Inflow / Outflow | ₹26 Cr | ₹-139 Cr | ₹90 Cr | ₹-11 Cr | ₹-8.64 Cr |
Opening Cash & Cash Equivalents | ₹19 Cr | ₹158 Cr | ₹68 Cr | ₹79 Cr | ₹88 Cr |
Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - | - | - | - |
Cash & Cash Equivalent of Subsidiaries under liquidations | - | - | - | - | - |
Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - | - | - | - |
Effect of Foreign Exchange Fluctuations | - | - | - | - | - |
Closing Cash & Cash Equivalent | ₹45 Cr | ₹19 Cr | ₹158 Cr | ₹68 Cr | ₹79 Cr |
Compare Cashflow Statement of peers of NOVARTIS INDIA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NOVARTIS INDIA | ₹2,500.3 Cr | -4.1% | -6.2% | 45.1% | Stock Analytics | |
ADANI ENTERPRISES | ₹283,351.0 Cr | -2.7% | -16.2% | -14.6% | Stock Analytics | |
REDINGTON | ₹16,710.4 Cr | 3.5% | 11.9% | 22.5% | Stock Analytics | |
MMTC | ₹12,175.5 Cr | 1.2% | 3.4% | 47.7% | Stock Analytics | |
HONASA CONSUMER | ₹8,450.3 Cr | -5% | -31.9% | -34.6% | Stock Analytics | |
MSTC | ₹5,458.8 Cr | 1.4% | 21.7% | 74% | Stock Analytics |
NOVARTIS INDIA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NOVARTIS INDIA | -4.1% |
-6.2% |
45.1% |
SENSEX | 0.7% |
2.5% |
17% |
You may also like the below Video Courses